Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study Immunologically Evaluating 5T4-MVA (TroVax) in Patients Undergoing Surgical Resection of Colorectal Liver Metastases

NCT00259844 is registered in ClinicalTrials.gov with Cancer Research UK as lead sponsor.

NCT NCT00259844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00259844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study Immunologically Evaluating 5T4-MVA (TroVax) in Patients Undergoing Surgical Resection of Colorectal Liver Metastases
Lead sponsor
Cancer Research UK
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2004
Completion date
December 31, 2006
Enrollment
20
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal neoplasms